Clinical Trial Update: Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells [Phase 3]

View source ↗

Summary

A Phase 3 trial is investigating mesenchymal stromal cells for chronic graft-versus-host disease. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Chronic Graft-Versus-Host Disease | Phase 3 | Status: UNKNOWN